Shares of Kwality Pharmaceuticals surged 16.85% to ₹964.90 in early trade on Tuesday after the company posted a stellar set of numbers for the fourth quarter ended March 2025. The stock hit a high of ₹990.90, up from the previous close of ₹825.75 on the BSE.
The pharmaceutical company reported a 232.34% year-on-year (YoY) increase in net profit to ₹14.49 crore in Q4 FY25, compared to ₹4.36 crore in the corresponding quarter of FY24. Revenue from operations also grew 25.77% YoY to ₹115.68 crore from ₹91.98 crore.
For the full financial year ended March 31, 2025, Kwality Pharmaceuticals reported a 67.44% jump in net profit to ₹39.85 crore, while annual revenue rose 20.52% to ₹370.20 crore.
The strong quarterly performance was supported by improved operational metrics, as the company maintained a healthy operating profit margin (OPM) of 22.37% during the quarter.
At the time of reporting, the stock traded with a market capitalization of ₹9.97 billion and a P/E ratio of 33.35.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
